Shock other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 32: | Line 32: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | ||
|- | |- | ||
Line 44: | Line 42: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | ||
|- | |- | ||
Line 58: | Line 53: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | ||
|- | |- | ||
Line 72: | Line 64: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑ | ||
|- | |- | ||
Line 86: | Line 75: | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑↑ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑ | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center | | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑ | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center | | |||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Cardiac tamponade|Cardiac Tamponade]]''' | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Cardiac tamponade|Cardiac Tamponade]]''' | ||
Line 101: | Line 87: | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑ | ||
|- | |- | ||
Line 116: | Line 99: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
|- | |- | ||
Line 130: | Line 110: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
|- | |- | ||
Line 145: | Line 122: | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | ||
|} | |} |
Latest revision as of 12:02, 16 May 2014
Shock Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Shock other diagnostic studies On the Web |
American Roentgen Ray Society Images of Shock other diagnostic studies |
Risk calculators and risk factors for Shock other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hemodynamic profile aids in classification of shock and is also valuable in directing fluid therapy in patients with cardiogenic shock.
Hemodynamic Profile
Type of Shock | Etiology | CO | SVR | PCWP | CVP | SVO2 | RVS | RVD | PAS | PAD |
Cardiogenic | Acute Ventricular Septal Defect | ↓↓ | ↑ | N — ↑ | ↑↑ | ↑ — ↑↑ | N — ↑ | ↑ | N — ↑ | N — ↑ |
Acute Mitral Regurgitation | ↓↓ | ↑ | ↑↑ | ↑ — ↑↑ | ↓ | ↑ | N — ↑ | ↑ | ↑ | |
Myocardial Dysfunction | ↓↓ | ↑ | ↑↑ | ↑↑ | ↓ | N — ↑ | N — ↑ | N — ↑ | ↑ | |
Right Ventricular Infarction | ↓↓ | ↑ | N — ↓ | ↑↑ | ↓ | ↓ — ↑ | ↑ | ↓ — ↑ | ↓ — ↑ | |
Obstructive | Pulmonary Embolism | ↓↓ | ↑ | N — ↓ | ↑↑ | ↓ | ↑ | ↑ | ↑ | ↑ |
Cardiac Tamponade | ↓ — ↓↓ | ↑ | ↑↑ | ↑↑ | ↓ | N — ↑ | ↑ | N — ↑ | N — ↑ | |
Distributive | Septic Shock | N — ↑↑ | ↓ — ↓↓ | N — ↓ | N — ↓ | ↑ — ↑↑ | N — ↓ | N — ↓ | ↓ | ↓ |
Anaphylactic Shock | N — ↑↑ | ↓ — ↓↓ | N — ↓ | N — ↓ | ↑ — ↑↑ | N — ↓ | N — ↓ | ↓ | ↓ | |
Hypovolemic | Volume Depletion | ↓↓ | ↑ | ↓↓ | ↓↓ | ↓ | N — ↓ | N — ↓ | ↓ | ↓ |
References
- ↑ Parrillo, Joseph E.; Ayres, Stephen M. (1984). Major issues in critical care medicine. Baltimore: William Wilkins. ISBN 0-683-06754-0.
- ↑ Judith S. Hochman, E. Magnus Ohman (2009). Cardiogenic Shock. Wiley-Blackwell. ISBN 9781405179263.